CClinicalTrials.gg
Status unknownNCT05450107FOOTUpdated Mar 2, 2023

Fifth Metatarsal Orthopedic Outcome Trial

An interventional study of Open Reduction Internal Fixation and Cast immobilisation in Metatarsal Fracture, sponsored by Isala. Status unknown at 3 sites in Netherlands. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-03-02.

Sponsored by Isala · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Feb 2023), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
64
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Fractures of the shaft, distal to zone three, of the fifth metatarsal often occur after foot distortion. There is very little evidence available regarding the optimal treatment. Currently the most common treatment is prolonged cast immobilization. Operative treatment has been reported as an alternative and could promote early recovery. No comparative study has been published regarding optimal treatment

Read the detailed description

Objective: The main objective is to determine experienced pain, as measured by NRS-11 score, 3 months after intervention and compare this between the intervention and control group. Secondary objectives are functional outcome as measured by AOFAS Lesser Toe Scale, FAAM score, progress of NRS-11 score through time and PROMIS Mobility/pain interference. Furthermore, quality and duration of fracture healing will be compared between groups. The impact on daily life will be compared as measured by duration of return to work and normal footwear.

Study design: Randomised controlled clinical intervention trial

Study population: Humans with an acute shaft fracture of the fifth metatarsal bone, 18 years or older.

02

Conditions studied

  • Metatarsal Fracture

Browse trials for

03

In context

Fractures, Bone

2,261 studies on the registry are indexed under Fractures, Bone; 325 are open to participants now.

This study's planned enrollment of 64 is close to the median of 69 across 1,482 interventional studies indexed under Fractures, Bone.

Browse Fractures, Bone studies →

Lead sponsor

Isala is the lead sponsor of 36 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • 18 years or older at the time of study entry
  • Informed consent
  • Competent to participate in follow up and fill out questionnaires
  • Dislocated (1mm or more on plain radiography) fracture of the shaft, distal from zone 3, of the fifth metatarsal according to the Orthopedic Trauma Association (OTA) classification 87.5.3 A-C

Exclusion criteria

Exclusion Criteria:

  • Open fracture
  • Proximal fifth metatarsal fracture, Jones fracture
  • Clinically significant or symptomatic vascular or neurologic pathology on the ipsilateral leg
  • Former surgery or history of development disorder of the contralateral fifth metatarsal
  • Multiple fractured metatarsals in the affected foot
  • Medical history of Rheumatoid Arthritis
  • Unable to undergo surgical procedure
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
64 participants (estimated)

Study arms

  • Experimental
    Intervention

    The intervention group is offered surgical treatment of the shaft fracture of the fifth metatarsal bone with ORIF. Depending on the type of shaft fracture this will be either lag screw fixation or plate fixation. After surgery a period of cast immobilisation with gradual increase of weight bearing will commence

    Procedure: Open Reduction Internal Fixation

  • Active comparator
    Control

    The control group (conservative treatment), will receive a period of cast immobilisation, with a gradual increase in weight bearing by protocol.

    Procedure: Cast immobilisation

Interventions

  • ProcedureOpen Reduction Internal Fixation

    Surgical intervention by lag screw or plate fixation

  • ProcedureCast immobilisation

    Cast immobilsation for a total of 6 weeks with gradual increase in weight bearing after 2 weeks

06

What researchers measure

Primary outcomes

  1. Numerical rating scale-11 score for pain 3 months

    Numerical rating scale, score ranging from 0-10 where 10 is a worse outcome

    Time frame: 3 months after intervention

Secondary outcomes

  1. Numerical rating scale-11 score for pain through time

    Numerical Rating Scale-11 score progression through different time points (6 weeks, 3,6 and 12 months after intervention. Score ranging from 0-10. A Higher score is a worse outcome

    Time frame: 0-12 months after intervention

  2. American Orthopedic Foot &Ankle Society Lesser Toe Scale

    American Orthopedic Foot \&Ankle Society Lesser Toe Scale between groups, functional outcome measure for patients with lesser toe (i.e. excluding hallux) and midfoot pathology. Score ranging from 0-100. A Higher score is a better outcome

    Time frame: 3 months after intervention

  3. Foot and Ankle Ability Measure

    Foot and Ankle Ability Measure, a score with two subscales: Activities of Daily Living (ADL) and sports. The questions concern function of the foot and ankle. progression through different time points (6 weeks, 3,6 and 12 months after intervention). Score ranging from 0-120. A higher score is a better outcome

    Time frame: 6 weeks, 3,6 and 12 months after intervention

  4. Patient Reported Outcome Measure Information System - Mobility

    patient reported outcome measures by using Computer Adaptive Testing. Results in a normalized score ranging from 0-100 where an average human being will score 50. Higher score is a better outcome.

    Time frame: 6 weeks, 3,6 and 12 months after intervention

  5. Patient Reported Outcome Measure Information System - Pain Interference

    Patient reported outcome measures by using Computer Adaptive Testing. Results in a normalized score ranging from 0-100 where an average human being will score 50. Higher score is a better outcome.

    Time frame: 6 weeks, 3,6 and 12 months after intervention

  6. Return to work

    Duration of resumption of work

    Time frame: 0-12 months

  7. Return to normal footwear

    Duration of return to normal footwear

    Time frame: 0-12 months

  8. Malunion

    Length of fractured fifth metatarsal as compared to ipsilateral fifth metatarsal

    Time frame: 6 weeks after intervention

  9. Non union

    Determined by plain X-ray on 6 weeks, 3 months and 6 months, categorical outcome

    Time frame: 0-6 months

07

Study locations

3 of 3 sites recruiting
  • Rijnstate ziekenhuis
    Arnhem, Gelderland 6815AD, Netherlands
    Recruiting
  • IsalaK
    Zwolle, Overijssel 8025AB, Netherlands
    Recruiting
  • Martini ziekenhuis
    Groningen, 9728NT, Netherlands
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 2, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05450107
Lead sponsor
Isala
Responsible party
Maarten Cornelissen (Coordinating Investigator, Isala) — Principal investigator
First posted
Jul 8, 2022
Start date
Sep 1, 2022
Primary completion
Jun 2024 (estimated)
Completion
Dec 2024 (estimated)
Last update
Mar 2, 2023

Study contacts

Maarten Cornelissen, MD
Contact
m.p.cornelissen@isala.nl
0886248117
Roelina Munnik-Hagewoud, PhD
Contact
r.munnik@isala.nl
0886245375
Rutger Zuurmond, MD, PhD
principal investigator · Isala

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Feb 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion